Re: Interleukin-2 in T1 papillary bladder carcinoma: regression of the marker lesion in 8 of 10 patients.
Gomella
L G
LG
McGinnis
D E
DE
Lattime
E C
EC
D002291:Carcinoma, Papillary / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D009367:Neoplasm Staging; D012074:Remission Induction; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology
D007376:Interleukin-2